Netherlands
Medical device market intelligence for Netherlands. Regulatory changes, competitor moves, and procurement trends.
Recent signals
ABILITY Neurotech has received MREC approval for an ALS BCI clinical trial in the Netherlands.
Philips launched SmartIQ software to improve image quality while reducing radiation dose in coronary imaging.
The Free Flow Medical Lung Tensioning Device System aims to treat severe emphysema by restoring lung elastic recoil.
Philips launched SmartIQ AI software to improve image quality in coronary imaging while reducing radiation doses.
A study will evaluate the feasibility of the CE-certified Tracmotion device for ESD in gastrointestinal patients.
Philips warns that HDDs in Azurion and Allura systems may degrade after six years, impacting imaging and movement.
The IceBERG registry evaluates the safety and efficacy of Gore's Iliac Branch Excluder devices in the Netherlands.
A completed study tested a breathing device's effect on blood pressure in type 2 diabetes patients with hypertension.
A study on 3D-printed hand orthoses aims to evaluate their effectiveness and cost compared to conventional orthoses.
A completed trial tested a full-body blue light device for treating atopic dermatitis with 150 patients involved.
A novel device for holmium-166 injection in radioembolization has completed clinical validation, enhancing dose control.
Philips warns that Azurion systems' float tabletop control may suffer mechanical wear, affecting table movement.
The GATE Trial evaluates endoscopic sutured gastroplasty's effect on glycemic control in obese type 2 diabetes patients.
A completed pilot study evaluated the TriGuard™HDH device during TAVR in 12 patients in the Netherlands.
An observational study will assess AI's role in using wearables to detect deterioration in advanced heart failure patients.
The clinical trial tested the tolerance and practicality of the Module AOX device in critically ill patients.
Philips Ultrasound LLC registered the Extended Compact Cart under Class I in EUDAMED with UDI-DI 00884838111721.
The BeneMACS study shows HeartMate II LVAD survival in non-transplant patients is equal or better than literature results.
A completed study evaluated the Pain Relief Patch's effectiveness for chronic back pain using specific light wavelengths.
The CPPF therapy study was terminated despite showing safety and efficacy in reducing postoperative bleeding after cardiac surgery.